CASC16: A Potential Cancer Drug Target and Biomarker (G643714)

Target Name: CASC16

NCBI ID: G643714

CASC16

Other Name(s): cancer susceptibility 16 | Cancer susceptibility 16 | LINC00918

CASC16: A Potential Cancer Drug Target and Biomarker

Cancer Susceptibility 16 (CASC16) is a protein that is expressed in a variety of tissues throughout the body, including the breast, lung, and gastrointestinal tract. It is also a key regulator of cell growth and division, and has been shown to play a role in the development and progression of many types of cancer.

CASC16 is a transmembrane protein that is composed of four distinct subunits that are held together by disulfide bonds. It is expressed in a variety of tissues throughout the body, including the breast, lung, and gastrointestinal tract, and has been shown to play a role in the development and progression of many types of cancer.

One of the most promising aspects of CASC16 is its potential as a drug target. Studies have shown that inhibiting the activity of CASC16 has the potential to be a powerful new cancer treatment. This is because CASC16 is involved in many important cellular processes that are necessary for the growth and survival of cancer cells. By blocking its activity, researchers may be able to inhibit the growth and spread of cancer cells, and potentially lead to a more effective cancer treatment.

CASC16 is also a potential biomarker for cancer. Its expression has been shown to be elevated in a variety of types of cancer, and it has been used as a biomarker in a variety of clinical trials. This suggests that it may be a useful indicator of the severity and spread of cancer, and could potentially be used as a target for personalized medicine.

Another promising aspect of CASC16 is its role in cell signaling.CASC16 is a key regulator of the TGF-β signaling pathway, which is a critical pathway that is involved in many important cellular processes, including cell growth, differentiation, and inflammation. This means that CASC16 is involved in many important cellular processes that are necessary for the survival and growth of cells.

In addition to its role in cell signaling, CASC16 is also involved in the regulation of cell adhesion.CASC16 is a key regulator of the cadherin adhesion molecule, which is a protein that is involved in the formation of tight junctions between cells. This means that CASC16 is involved in the process of cell-cell adhesion, which is important for the proper functioning of tissues and organs.

CASC16 is also involved in the regulation of cell apoptosis.CASC16 is a key regulator of cell apoptosis, which is the process by which cells die when they have reached a certain level of dysfunction or when they are no longer needed. This is important because cell apoptosis is a natural process that helps to remove damaged or dysfunctional cells from the body, and is important for maintaining the health and integrity of tissues and organs.

In conclusion, CASC16 is a protein that is involved in many important cellular processes that are necessary for the growth and survival of cells. Its potential as a drug target and biomarker make it an attractive target for cancer researchers, and its role in cell signaling, adhesion, and apoptosis make it a promising target for personalized medicine. Further studies are needed to fully understand the role of CASC16 in cancer and to develop effective treatments.

Protein Name: Cancer Susceptibility 16

The "CASC16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CASC16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets